ID   UBP4_HUMAN              Reviewed;         963 AA.
AC   Q13107; A8K6Y0; C9IY91; O43452; O43453; Q08AK8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   15-MAR-2017, entry version 164.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 4;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 4;
DE   AltName: Full=Ubiquitin thioesterase 4;
DE   AltName: Full=Ubiquitin-specific-processing protease 4;
DE   AltName: Full=Ubiquitous nuclear protein homolog;
GN   Name=USP4; Synonyms=UNP, UNPH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=7784062;
RA   Gray D.A., Inazawa J., Gupta K., Wong A., Ueda R., Takahashi T.;
RT   "Elevated expression of Unph, a proto-oncogene at 3p21.3, in human
RT   lung tumors.";
RL   Oncogene 10:2179-2183(1995).
RN   [2]
RP   SEQUENCE REVISION.
RA   Gray D.A.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=B-cell, and T-cell;
RX   PubMed=9464533; DOI=10.1038/sj.onc.1201537;
RA   Frederick A., Rolfe M., Chiu M.I.;
RT   "The human UNP locus at 3p21.31 encodes two tissue-selective,
RT   cytoplasmic isoforms with deubiquitinating activity that have reduced
RT   expression in small cell lung carcinoma cell lines.";
RL   Oncogene 16:153-165(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH RB1, AND MUTAGENESIS OF GLU-463 AND 459-LEU--GLU-463.
RX   PubMed=11571652; DOI=10.1038/sj.onc.1204824;
RA   DeSalle L.M., Latres E., Lin D., Graner E., Montagnoli A., Baker R.T.,
RA   Pagano M., Loda M.;
RT   "The de-ubiquitinating enzyme Unp interacts with the retinoblastoma
RT   protein.";
RL   Oncogene 20:5538-5542(2001).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-311.
RX   PubMed=16316627; DOI=10.1016/j.bbrc.2005.11.076;
RA   Wada K., Tanji K., Kamitani T.;
RT   "Oncogenic protein UnpEL/Usp4 deubiquitinates Ro52 by its isopeptidase
RT   activity.";
RL   Biochem. Biophys. Res. Commun. 339:731-736(2006).
RN   [9]
RP   FUNCTION, AUTODEUBIQUITINATION, UBIQUITINATION BY TRIM21, AND
RP   MUTAGENESIS OF CYS-311.
RX   PubMed=16472766; DOI=10.1016/j.bbrc.2006.01.144;
RA   Wada K., Kamitani T.;
RT   "UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself.";
RL   Biochem. Biophys. Res. Commun. 342:253-258(2006).
RN   [10]
RP   FUNCTION, INTERACTION WITH ADORA2A, AND TISSUE SPECIFICITY.
RX   PubMed=16339847; DOI=10.1124/mol.105.015818;
RA   Milojevic T., Reiterer V., Stefan E., Korkhov V.M., Dorostkar M.M.,
RA   Ducza E., Ogris E., Boehm S., Freissmuth M., Nanoff C.;
RT   "The ubiquitin-specific protease Usp4 regulates the cell surface level
RT   of the A2A receptor.";
RL   Mol. Pharmacol. 69:1083-1094(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH SART3, AND SUBCELLULAR LOCATION.
RX   PubMed=20595234; DOI=10.1101/gad.1925010;
RA   Song E.J., Werner S.L., Neubauer J., Stegmeier F., Aspden J., Rio D.,
RA   Harper J.W., Elledge S.J., Kirschner M.W., Rape M.;
RT   "The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control
RT   reversible ubiquitination at the spliceosome.";
RL   Genes Dev. 24:1434-1447(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   DEUBIQUITINATION OF PDPK1.
RX   PubMed=22347420; DOI=10.1371/journal.pone.0031003;
RA   Uras I.Z., List T., Nijman S.M.;
RT   "Ubiquitin-specific protease 4 inhibits mono-ubiquitination of the
RT   master growth factor signaling kinase PDK1.";
RL   PLoS ONE 7:E31003-E31003(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 296-932, DOMAINS
RP   UBIQUITIN-LIKE, AND ZINC-BINDING SITES.
RX   PubMed=21415856; DOI=10.1038/embor.2011.33;
RA   Luna-Vargas M.P., Faesen A.C., van Dijk W.J., Rape M., Fish A.,
RA   Sixma T.K.;
RT   "Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like
RT   domain.";
RL   EMBO Rep. 12:365-372(2011).
CC   -!- FUNCTION: Hydrolase that deubiquitinates target proteins such as
CC       the receptor ADORA2A, PDPK1 and TRIM21. Deubiquitination of
CC       ADORA2A increases the amount of functional receptor at the cell
CC       surface. May regulate mRNA splicing through deubiquitination of
CC       the U4 spliceosomal protein PRPF3. This may prevent its
CC       recognition by the U5 component PRPF8 thereby destabilizing
CC       interactions within the U4/U6.U5 snRNP. May also play a role in
CC       the regulation of quality control in the ER.
CC       {ECO:0000269|PubMed:16316627, ECO:0000269|PubMed:16339847,
CC       ECO:0000269|PubMed:16472766, ECO:0000269|PubMed:20595234,
CC       ECO:0000269|PubMed:7784062}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC   -!- SUBUNIT: Interacts with RB1 (both dephosphorylated and
CC       hypophosphorylated forms). Interacts with RBL1 and RBL2. Interacts
CC       with ADORA2A (via cytoplasmic C-terminus); the interaction is
CC       direct. Interacts with SART3; recruits USP4 to its substrate
CC       PRPF3. {ECO:0000250|UniProtKB:P35123, ECO:0000269|PubMed:11571652,
CC       ECO:0000269|PubMed:16339847, ECO:0000269|PubMed:20595234}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-723290, EBI-723290;
CC       P29274:ADORA2A; NbExp=4; IntAct=EBI-723290, EBI-2902702;
CC       Q7Z6Z7:HUWE1; NbExp=4; IntAct=EBI-723290, EBI-625934;
CC       Q13546:RIPK1; NbExp=4; IntAct=EBI-723290, EBI-358507;
CC       P19474:TRIM21; NbExp=3; IntAct=EBI-723305, EBI-81290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16316627,
CC       ECO:0000269|PubMed:20595234}. Nucleus
CC       {ECO:0000269|PubMed:16316627, ECO:0000269|PubMed:20595234}.
CC       Note=Shuttles between the nucleus and cytoplasm. Exported to the
CC       cytoplasm in a CRM1-dependent manner and recycled back to the
CC       nucleus via the importin alpha/beta heterodimeric import receptor.
CC       The relative amounts found in the nucleus and cytoplasm vary
CC       according to the cell type. {ECO:0000269|PubMed:16316627,
CC       ECO:0000269|PubMed:20595234}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=UnpEL;
CC         IsoId=Q13107-1; Sequence=Displayed;
CC       Name=2; Synonyms=UnpES;
CC         IsoId=Q13107-2; Sequence=VSP_005258;
CC       Name=3;
CC         IsoId=Q13107-3; Sequence=VSP_044814, VSP_044815;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Overexpressed in small cell tumors and
CC       adenocarcinomas of the lung compared to wild-type lung (at protein
CC       level). Expressed in the hippocampal neurons.
CC       {ECO:0000269|PubMed:16339847, ECO:0000269|PubMed:7784062}.
CC   -!- DOMAIN: The Ubiquitin-like domain 2 inserts into the catalytic
CC       domain and competes with the ubiquitin substrate, partially
CC       inhibiting DUB activity. {ECO:0000269|PubMed:21415856}.
CC   -!- PTM: Monoubiquitinated by TRIM21. Ubiquitination does not lead to
CC       its proteasomal degradation. Autodeubiquitinated.
CC       {ECO:0000269|PubMed:16472766, ECO:0000269|PubMed:22347420}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. USP4 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U20657; AAB72237.1; -; mRNA.
DR   EMBL; AF017305; AAC27355.1; -; mRNA.
DR   EMBL; AF017306; AAC27356.1; -; mRNA.
DR   EMBL; AK291795; BAF84484.1; -; mRNA.
DR   EMBL; AC121247; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC068017; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC125130; AAI25131.1; -; mRNA.
DR   CCDS; CCDS2793.1; -. [Q13107-1]
DR   CCDS; CCDS2794.1; -. [Q13107-2]
DR   CCDS; CCDS58832.1; -. [Q13107-3]
DR   PIR; T09478; T09478.
DR   RefSeq; NP_001238806.1; NM_001251877.1. [Q13107-3]
DR   RefSeq; NP_003354.2; NM_003363.3. [Q13107-1]
DR   RefSeq; NP_955475.1; NM_199443.2. [Q13107-2]
DR   UniGene; Hs.403828; -.
DR   UniGene; Hs.77500; -.
DR   PDB; 2Y6E; X-ray; 2.40 A; A/B/C/D/E/F=296-490, A/B/C/D/E/F=765-932.
DR   PDB; 5CTR; X-ray; 3.01 A; C/D=1-230.
DR   PDBsum; 2Y6E; -.
DR   PDBsum; 5CTR; -.
DR   ProteinModelPortal; Q13107; -.
DR   SMR; Q13107; -.
DR   BioGrid; 113221; 106.
DR   IntAct; Q13107; 32.
DR   MINT; MINT-3027027; -.
DR   STRING; 9606.ENSP00000265560; -.
DR   BindingDB; Q13107; -.
DR   ChEMBL; CHEMBL2406900; -.
DR   MEROPS; C19.010; -.
DR   iPTMnet; Q13107; -.
DR   PhosphoSitePlus; Q13107; -.
DR   BioMuta; USP4; -.
DR   DMDM; 116242839; -.
DR   EPD; Q13107; -.
DR   MaxQB; Q13107; -.
DR   PaxDb; Q13107; -.
DR   PeptideAtlas; Q13107; -.
DR   PRIDE; Q13107; -.
DR   Ensembl; ENST00000265560; ENSP00000265560; ENSG00000114316. [Q13107-1]
DR   Ensembl; ENST00000351842; ENSP00000341028; ENSG00000114316. [Q13107-2]
DR   Ensembl; ENST00000416417; ENSP00000400623; ENSG00000114316. [Q13107-3]
DR   GeneID; 7375; -.
DR   KEGG; hsa:7375; -.
DR   UCSC; uc003cwq.3; human. [Q13107-1]
DR   CTD; 7375; -.
DR   DisGeNET; 7375; -.
DR   GeneCards; USP4; -.
DR   HGNC; HGNC:12627; USP4.
DR   HPA; HPA018499; -.
DR   MIM; 603486; gene.
DR   neXtProt; NX_Q13107; -.
DR   OpenTargets; ENSG00000114316; -.
DR   PharmGKB; PA37252; -.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000152636; -.
DR   HOVERGEN; HBG000864; -.
DR   InParanoid; Q13107; -.
DR   KO; K11835; -.
DR   OMA; MEIFLVP; -.
DR   OrthoDB; EOG091G0157; -.
DR   PhylomeDB; Q13107; -.
DR   TreeFam; TF106276; -.
DR   Reactome; R-HSA-5357786; TNFR1-induced proapoptotic signaling.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP4; human.
DR   EvolutionaryTrace; Q13107; -.
DR   GeneWiki; USP4; -.
DR   GenomeRNAi; 7375; -.
DR   PRO; PR:Q13107; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114316; -.
DR   CleanEx; HS_USP4; -.
DR   ExpressionAtlas; Q13107; baseline and differential.
DR   Genevisible; Q13107; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0031685; F:adenosine receptor binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0000244; P:spliceosomal tri-snRNP complex assembly; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.2230.10; -; 1.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR028135; Ub_USP-typ.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF06337; DUSP; 1.
DR   Pfam; PF14836; Ubiquitin_3; 1.
DR   Pfam; PF00443; UCH; 1.
DR   SMART; SM00695; DUSP; 1.
DR   SUPFAM; SSF143791; SSF143791; 1.
DR   PROSITE; PS51283; DUSP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Hydrolase; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Protease; Proto-oncogene; Reference proteome; Repeat; Thiol protease;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc.
FT   CHAIN         1    963       Ubiquitin carboxyl-terminal hydrolase 4.
FT                                /FTId=PRO_0000080621.
FT   DOMAIN       11    122       DUSP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      142    226       Ubiquitin-like 1.
FT   DOMAIN      302    923       USP.
FT   DOMAIN      483    571       Ubiquitin-like 2.
FT   REGION       27    216       Necessary for interaction with SART3.
FT                                {ECO:0000269|PubMed:20595234}.
FT   REGION      405    407       Necessary for interaction with RBL2.
FT                                {ECO:0000250}.
FT   REGION      459    463       Necessary for interaction with RB1 and
FT                                RBL2. {ECO:0000250}.
FT   MOTIF       133    141       Nuclear export signal. {ECO:0000250}.
FT   MOTIF       767    772       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   ACT_SITE    311    311       Nucleophile.
FT   ACT_SITE    881    881       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   METAL       461    461       Zinc.
FT   METAL       464    464       Zinc.
FT   METAL       799    799       Zinc.
FT   METAL       802    802       Zinc.
FT   MOD_RES     655    655       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:B2GUZ1}.
FT   MOD_RES     675    675       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35123}.
FT   MOD_RES     680    680       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35123}.
FT   VAR_SEQ     232    279       KSSTAPSRNFTTSPKSSASPYSSVSASLIANGDSTSTCGMH
FT                                SSGVSRG -> N (in isoform 2).
FT                                {ECO:0000303|PubMed:9464533}.
FT                                /FTId=VSP_005258.
FT   VAR_SEQ     233    313       SSTAPSRNFTTSPKSSASPYSSVSASLIANGDSTSTCGMHS
FT                                SGVSRGGSGFSASYNCQEPPSSHIQPGLCGLGNLGNTCFM
FT                                -> VSFFLPRLECNGAILAHCNFCLPGSSNSPASASRVAPS
FT                                HLANFFFFEMESHSVTKLECGGAVSAYSRVQVMLLPQPPEW
FT                                LG (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044814.
FT   VAR_SEQ     314    963       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044815.
FT   VARIANT     620    620       Y -> C (in dbSNP:rs9311440).
FT                                /FTId=VAR_028180.
FT   MUTAGEN     311    311       C->A: Loss of activity. Its
FT                                ubiquitination by TRIM21 is enhanced.
FT                                {ECO:0000269|PubMed:16316627,
FT                                ECO:0000269|PubMed:16472766}.
FT   MUTAGEN     459    463       LVCPE->AVRPH: Reduces the interaction
FT                                with RB1. {ECO:0000269|PubMed:11571652}.
FT   MUTAGEN     463    463       E->Q: Reduces the interaction with RB1.
FT                                {ECO:0000269|PubMed:11571652}.
FT   CONFLICT    373    373       R -> S (in Ref. 1; AAB72237).
FT                                {ECO:0000305}.
FT   CONFLICT    744    744       S -> R (in Ref. 1; AAB72237).
FT                                {ECO:0000305}.
FT   HELIX        13     20       {ECO:0000244|PDB:5CTR}.
FT   HELIX        21     23       {ECO:0000244|PDB:5CTR}.
FT   STRAND       32     38       {ECO:0000244|PDB:5CTR}.
FT   HELIX        39     48       {ECO:0000244|PDB:5CTR}.
FT   HELIX        62     64       {ECO:0000244|PDB:5CTR}.
FT   TURN         72     74       {ECO:0000244|PDB:5CTR}.
FT   STRAND       75     77       {ECO:0000244|PDB:5CTR}.
FT   TURN         78     81       {ECO:0000244|PDB:5CTR}.
FT   TURN         89     92       {ECO:0000244|PDB:5CTR}.
FT   STRAND       93     97       {ECO:0000244|PDB:5CTR}.
FT   HELIX        98    108       {ECO:0000244|PDB:5CTR}.
FT   STRAND      118    124       {ECO:0000244|PDB:5CTR}.
FT   STRAND      126    128       {ECO:0000244|PDB:5CTR}.
FT   STRAND      130    133       {ECO:0000244|PDB:5CTR}.
FT   STRAND      140    143       {ECO:0000244|PDB:5CTR}.
FT   STRAND      151    154       {ECO:0000244|PDB:5CTR}.
FT   STRAND      158    161       {ECO:0000244|PDB:5CTR}.
FT   HELIX       162    172       {ECO:0000244|PDB:5CTR}.
FT   STRAND      177    179       {ECO:0000244|PDB:5CTR}.
FT   STRAND      183    185       {ECO:0000244|PDB:5CTR}.
FT   STRAND      187    191       {ECO:0000244|PDB:5CTR}.
FT   STRAND      198    202       {ECO:0000244|PDB:5CTR}.
FT   TURN        203    206       {ECO:0000244|PDB:5CTR}.
FT   HELIX       311    321       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       324    331       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       335    338       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       350    362       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      364    366       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      368    370       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       373    382       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       384    386       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      388    390       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       394    408       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       428    442       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       446    451       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      453    460       {ECO:0000244|PDB:2Y6E}.
FT   TURN        462    464       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      467    480       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       778    785       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      797    799       {ECO:0000244|PDB:2Y6E}.
FT   TURN        800    803       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      804    806       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      809    816       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      819    826       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      828    830       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      835    837       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       852    854       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      858    860       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      864    874       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      876    879       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      881    887       {ECO:0000244|PDB:2Y6E}.
FT   TURN        889    891       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      894    898       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      901    904       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       907    909       {ECO:0000244|PDB:2Y6E}.
FT   STRAND      915    922       {ECO:0000244|PDB:2Y6E}.
FT   HELIX       926    928       {ECO:0000244|PDB:2Y6E}.
SQ   SEQUENCE   963 AA;  108565 MW;  63055C9ADFE36713 CRC64;
     MAEGGGCRER PDAETQKSEL GPLMRTTLQR GAQWYLIDSR WFKQWKKYVG FDSWDMYNVG
     EHNLFPGPID NSGLFSDPES QTLKEHLIDE LDYVLVPTEA WNKLLNWYGC VEGQQPIVRK
     VVEHGLFVKH CKVEVYLLEL KLCENSDPTN VLSCHFSKAD TIATIEKEMR KLFNIPAERE
     TRLWNKYMSN TYEQLSKLDN TVQDAGLYQG QVLVIEPQNE DGTWPRQTLQ SKSSTAPSRN
     FTTSPKSSAS PYSSVSASLI ANGDSTSTCG MHSSGVSRGG SGFSASYNCQ EPPSSHIQPG
     LCGLGNLGNT CFMNSALQCL SNTAPLTDYF LKDEYEAEIN RDNPLGMKGE IAEAYAELIK
     QMWSGRDAHV APRMFKTQVG RFAPQFSGYQ QQDSQELLAF LLDGLHEDLN RVKKKPYLEL
     KDANGRPDAV VAKEAWENHR LRNDSVIVDT FHGLFKSTLV CPECAKVSVT FDPFCYLTLP
     LPLKKDRVME VFLVPADPHC RPTQYRVTVP LMGAVSDLCE ALSRLSGIAA ENMVVADVYN
     HRFHKIFQMD EGLNHIMPRD DIFVYEVCST SVDGSECVTL PVYFRERKSR PSSTSSASAL
     YGQPLLLSVP KHKLTLESLY QAVCDRISRY VKQPLPDEFG SSPLEPGACN GSRNSCEGED
     EEEMEHQEEG KEQLSETEGS GEDEPGNDPS ETTQKKIKGQ PCPKRLFTFS LVNSYGTADI
     NSLAADGKLL KLNSRSTLAM DWDSETRRLY YDEQESEAYE KHVSMLQPQK KKKTTVALRD
     CIELFTTMET LGEHDPWYCP NCKKHQQATK KFDLWSLPKI LVVHLKRFSY NRYWRDKLDT
     VVEFPIRGLN MSEFVCNLSA RPYVYDLIAV SNHYGAMGVG HYTAYAKNKL NGKWYYFDDS
     NVSLASEDQI VTKAAYVLFY QRRDDEFYKT PSLSSSGSSD GGTRPSSSQQ GFGDDEACSM
     DTN
//
